Homeostatic chemokine receptors and organ-specific metastasis
- 25 August 2011
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Reviews Immunology
- Vol. 11 (9), 597-606
- https://doi.org/10.1038/nri3049
Abstract
It has been 10 years since the role of a chemokine receptor, CXCR4, in breast cancer metastasis was first documented. Since then, the field of chemokines and cancer has grown significantly, so it is timely to review the progress, analyse the studies to date and identify future challenges facing this field. Metastasis is the major factor that limits survival in most patients with cancer. Therefore, understanding the molecular mechanisms that control the metastatic behaviour of tumour cells is pivotal for treating cancer successfully. Substantial experimental and clinical evidence supports the conclusion that molecular mechanisms control organ-specific metastasis. One of the most important mechanisms operating in metastasis involves homeostatic chemokines and their receptors. Here, we review this field and propose a model of 'cellular highways' to explain the effects of homeostatic chemokines on cancer cells and how they influence metastasis.Keywords
This publication has 121 references indexed in Scilit:
- CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasisNature, 2011
- Effect of Occult Metastases on Survival in Node-Negative Breast CancerThe New England Journal of Medicine, 2011
- Re-expression of CXCL14, a common target for epigenetic silencing in lung cancer, induces tumor necrosisOncogene, 2010
- High expression of CXCR4 may predict poor survival in resected pancreatic adenocarcinomaBritish Journal of Cancer, 2009
- CXCR4 mediates the proliferation of glioblastoma progenitor cellsCancer Letters, 2009
- Nuclear Localization of CXCR4 Determines Prognosis for Colorectal Cancer PatientsCancer Microenvironment, 2008
- Tumor immune escape by the loss of homeostatic chemokine expressionProceedings of the National Academy of Sciences of the United States of America, 2007
- The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesisProceedings of the National Academy of Sciences of the United States of America, 2006
- Gene expression profiling predicts clinical outcome of breast cancerNature, 2002
- Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar developmentNature, 1998